Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.
The overall tone suggests a moderate interest and agreement with the study, as discussions mention key details like the 10% vaccine failure rate and the mild symptoms among breakthrough cases, often using straightforward language that indicates recognition of the study's relevance while not delving deeply into methodological critiques or broader implications.
AgreementModerate agreement
Most discussions acknowledge the findings, such as the 10% breakthrough infection rate and the observed mild symptoms, showing moderate support for the study's conclusions.
InterestModerate interest
The discussions reflect a moderate level of curiosity, focusing on vaccine effectiveness and implications for public health, but lack deep analysis or critique.
EngagementModerate engagement
Participants reference specific data points like the 10% failure rate and mention related institutions or ongoing discussions, indicating an engaged but not intensive level of interaction.
ImpactModerate impact
The conversation recognizes the importance of the findings for understanding vaccine outcomes and public health strategies, signifying a moderate perceived impact.
Abstract in brief
The Modified vaccinia virus Ankara (MVA-BN) vaccine is recommended for individuals who have been exposed to mpox within 14 days, but its effectiveness remains uncertain.
In a study of 108 adults who received the vaccine after exposure, 10% experienced breakthrough mpox infections.
Sexual contact was identified as a significant risk factor for these breakthrough cases, and vaccinated individuals had similar rates of infectious virus presence compared to unvaccinated cases.
A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Boghuma https://t.co/5BeULCs003
Dec 15, 2022 · 11 likes · 5 shares · 207,202 followersView post →
M無
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X
mpoxに対してMVA-BNを用いた曝露後予防接種では108人が曝露後14日以内に1回接種し、10%がブレイクスルー感染が生じた
性的接触による曝露がブレイクスルーに関連
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox
https://t.co/WsKsUHBm2Z https://t.co/5OOlrguCRG https://t.co/5ZhMn7BEZc
Dec 21, 2022 · 6 likes · 12,355 followersView post →
E
Eurosurveillance
@Eurosurveillanc · X
@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
Dec 18, 2022 · 2 likes · 1 share · 16,590 followersView post →
E
Eurosurveillance
@Eurosurveillanc · X
@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU @Y_Merad @DulceAlfaiate Of 108 adults who received one dose of MVA-BN after exposure to #mpox
Dec 21, 2022 · 1 like · 1 share · 16,590 followersView post →
ES
EUPHA-IDC section
@EuphaIdc · X
Eurosurveillanc: RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Bog… https://t.co/RvkqOytn0e
Eurosurveillanc: @rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
… https://t.co/tDu1kZWdTR
Are you concerned about the risk of Mpox formerly known as Monkeypox and eager to take proactive steps to protect yourself. In this video, we share the best strategies to prevent mpox permanently and protect yourself…
This video covers the growing concern over Mpox, formerly known as Monkeypox, including symptoms, transmission, and prevention. It also explores vaccine development strategies and research to improve control and…
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 https://t.co/VKuCvjOOuB
mpoxに対してMVA-BNを用いた曝露後予防接種では108人が曝露後14日以内に1回接種し、10%がブレイクスルー感染が生じた
性的接触による曝露がブレイクスルーに関連
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox
https://t.co/WsKsUHBm2Z https://t.co/5OOlrguCRG https://t.co/5ZhMn7BEZc
Dec 21, 2022 · 6 likes · 12,355 followersView post →
E
Eurosurveillance
@Eurosurveillanc · X
@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU @Y_Merad @DulceAlfaiate Of 108 adults who received one dose of MVA-BN after exposure to #mpox
Dec 21, 2022 · 1 like · 1 share · 16,590 followersView post →
HV
HAS-veille
@HAS_veille · X
Eurosurveillance | Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 https://t.co/NWvHj02HpX
Eurosurveillanc: @rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
… https://t.co/tDu1kZWdTR
@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
Dec 18, 2022 · 2 likes · 1 share · 16,590 followersView post →
V
V.
@drmom01 · X
RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…
Dec 16, 2022 · 5 shares · 473 followersView post →
MD
MaryAnn Decker
@MaryAnn27608053 · X
RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…
Dec 16, 2022 · 5 shares · 365 followersView post →
DB
Donal BIsanzio
@donal_bisanzio · X
RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…
Dec 15, 2022 · 5 shares · 1,380 followersView post →
DL
D'Ombre et de Lumière
@louvetou · X
RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…
Dec 15, 2022 · 5 shares · 133 followersView post →
ES
EUPHA-IDC section
@EuphaIdc · X
Eurosurveillanc: RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Bog… https://t.co/RvkqOytn0e
RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…
Dec 15, 2022 · 5 shares · 16,590 followersView post →
HB
Helen Branswell
@HelenBranswell · X
A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Boghuma https://t.co/5BeULCs003
Dec 15, 2022 · 11 likes · 5 shares · 207,202 followersView post →
B
Study examines Mpox prevention with modified vaccinia Ankara (MVA)
Blogs
https://doi.org/10.2807/1560-7917.ES.2022.27.50.2200882, https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.50.2200882. Be ...